Results
|
481.
|
|
|
482.
|
|
|
483.
|
|
|
484.
|
Maintenance Defactinib Versus Placebo After First-Line Chemotherapy in Patients With Merlin-Stratified Pleural Mesothelioma: COMMAND-A Double-Blind, Randomized, Phase II Study. [electronic resource] by
- Fennell, Dean A
- Baas, Paul
- Taylor, Paul
- Nowak, Anna K
- Gilligan, David
- Nakano, Takashi
- Pachter, Jonathan A
- Weaver, David T
- Scherpereel, Arnaud
- Pavlakis, Nick
- van Meerbeeck, Jan P
- Cedrés, Susana
- Nolan, Luke
- Kindler, Hedy
- Aerts, Joachim G J V
Producer: 20200224
In:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology vol. 37
Availability: No items available.
|
|
485.
|
|
|
486.
|
|
|
487.
|
|
|
488.
|
|
|
489.
|
Molecular characterisation of SMARCB1 and NF2 in familial and sporadic schwannomatosis. [electronic resource] by
- Hadfield, K D
- Newman, W G
- Bowers, N L
- Wallace, A
- Bolger, C
- Colley, A
- McCann, E
- Trump, D
- Prescott, T
- Evans, D G R
Producer: 20080811
In:
Journal of medical genetics vol. 45
Availability: No items available.
|
|
490.
|
|
|
491.
|
|
|
492.
|
NF2/Merlin mediates contact-dependent inhibition of EGFR mobility and internalization via cortical actomyosin. [electronic resource] by
- Chiasson-MacKenzie, Christine
- Morris, Zachary S
- Baca, Quentin
- Morris, Brett
- Coker, Joanna K
- Mirchev, Rossen
- Jensen, Anne E
- Carey, Thomas
- Stott, Shannon L
- Golan, David E
- McClatchey, Andrea I
Producer: 20160217
In:
The Journal of cell biology vol. 211
Availability: No items available.
|
|
493.
|
|
|
494.
|
|
|
495.
|
Co-targeting of FAK and MDM2 triggers additive anti-proliferative effects in mesothelioma via a coordinated reactivation of p53. [electronic resource] by
- Ou, Wen-Bin
- Lu, Minmin
- Eilers, Grant
- Li, Hailong
- Ding, Jiongyan
- Meng, Xuli
- Wu, Yuehong
- He, Quan
- Sheng, Qing
- Zhou, Hai-Meng
- Fletcher, Jonathan A
Producer: 20170606
In:
British journal of cancer vol. 115
Availability: No items available.
|
|
496.
|
|
|
497.
|
|
|
498.
|
|
|
499.
|
Combination therapy with mTOR kinase inhibitor and dasatinib as a novel therapeutic strategy for vestibular schwannoma. [electronic resource] by
- Sagers, Jessica E
- Beauchamp, Roberta L
- Zhang, Yanling
- Vasilijic, Sasa
- Wu, Limeng
- DeSouza, Patrick
- Seist, Richard
- Zhou, Wenjianlong
- Xu, Lei
- Ramesh, Vijaya
- Stankovic, Konstantina M
Producer: 20201123
In:
Scientific reports vol. 10
Availability: No items available.
|
|
500.
|
|